Double Trouble: Concomitant RB1 and BRCA2 Depletion Evokes Aggressive Phenotypes

Amy C Mandigo1, Karen E Knudsen2,3,4,5,6

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

Insights

Loss of BRCA2 and RB1 tumor suppressor genes is linked to aggressive prostate cancer and treatment resistance. This dual gene loss may define a unique prostate cancer subtype.

Area of Science:

  • Genetics and Genomics
  • Oncology
  • Molecular Biology

Background:

  • The BRCA2 and RB1 tumor suppressor genes are critical for maintaining genomic stability.
  • These genes are located in close proximity on the same chromosome, suggesting coordinated regulation or loss.
  • Alterations in tumor suppressor genes are frequently implicated in cancer development and progression.

Purpose of the Study:

  • To investigate the association between copy loss of BRCA2 and RB1 genes and prostate cancer aggressiveness.
  • To explore whether combined loss of BRCA2 and RB1 constitutes a distinct molecular subtype of prostate cancer.
  • To understand the implications of dual BRCA2/RB1 gene depletion in therapeutic resistance.

Main Methods:

  • Analysis of human prostate cancer samples to assess copy number variations of BRCA2 and RB1.
  • Computational modeling to simulate the effects of single and dual gene loss.
  • Correlation analysis between gene copy loss and clinical parameters such as cancer stage and treatment response.

Main Results:

  • Coordinate single or two copy loss of both BRCA2 and RB1 tumor suppressor genes was observed.
  • This dual gene loss was significantly associated with more aggressive forms of prostate cancer.
  • The findings suggest that combined BRCA2/RB1 depletion may represent a distinct disease subtype characterized by therapeutic resistance.

Conclusions:

  • Dual loss of BRCA2 and RB1 is a recurrent event in prostate cancer.
  • This genetic event is linked to aggressive disease phenotypes and resistance to therapies.
  • Identifying dual BRCA2/RB1 loss could aid in classifying a specific prostate cancer subtype and guiding treatment strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K